Carl Regillo, MD, explains why wet AMD anti‑VEGF results lag in real life and how newer agents extend dosing, yet the burden persists.
Carl Regillo, MD, FASRS
Advertisement
Carl Regillo, MD, FASRS, is the chief of retina service at Wills Eye Hospital and a professor of ophthalmology at Sidney Kimmel Medical College, Thomas Jefferson University.
Articles by Carl Regillo, MD, FASRS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Ocrelizumab Led to Declines in Immunoglobulins in Patients With MS
2
House Panel Advances Bills to Expand Veterans’ Health Care Access
3
House Passes Bill to Ease Medicare ACO Digital Quality Reporting Burden
4
The Oncology Care Model: A Decade of Transformation
5